Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.585 USD | -6.29% | -12.74% | +10.56% |
05-09 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
Sales 2024 * | 108M 148M | Sales 2025 * | 277M 381M | Capitalization | 4.12B 5.67B |
---|---|---|---|---|---|
Net income 2024 * | -437M -601M | Net income 2025 * | -307M -422M | EV / Sales 2024 * | 38.2 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 14.9 x |
P/E ratio 2024 * |
-7.1
x | P/E ratio 2025 * |
-11.8
x | Employees | 628 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 22.2% |
Latest transcript on ImmunityBio, Inc.
1 day | -4.49% | ||
1 week | -3.09% | ||
Current month | -7.17% | ||
1 month | -26.60% | ||
3 months | +15.95% | ||
6 months | +87.42% | ||
Current year | +18.73% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Adcock
CEO | Chief Executive Officer | 55 | 20-09-30 |
Founder | 71 | 14-11-30 | |
David Sachs
DFI | Director of Finance/CFO | 46 | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 71 | 14-11-30 | |
Cheryl Cohen
BRD | Director/Board Member | 58 | 19-05-31 |
Wesley Clark
BRD | Director/Board Member | 78 | 21-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.04% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.02% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 5.53 | -7.21% | 4 291 214 |
24-06-11 | 5.96 | -4.49% | 4,790,981 |
24-06-10 | 6.24 | +2.30% | 3,096,818 |
24-06-07 | 6.1 | +0.16% | 2,496,286 |
24-06-06 | 6.09 | -4.25% | 2,265,073 |
Delayed Quote Nasdaq, June 11, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.73% | 4.12B | |
+18.34% | 124B | |
+15.06% | 109B | |
-6.39% | 23.84B | |
+0.96% | 22.42B | |
-14.90% | 17.5B | |
-41.64% | 16.43B | |
-12.07% | 16.61B | |
+1.05% | 13.4B | |
+25.87% | 11.47B |
- Stock Market
- Equities
- IBRX Stock